Explore how Porton/J-STAR Research, Inc. #pharmaceutical pioneers uncover unidentified impurities and #metabolites, raising the bar for Structural Elucidation standards. Leveraging the microgram sample requirement of our cryoprobe NMR, Porton/J-Star’s experts led by Frank Rinaldi and Robert Reamer recently helped a client facing dozens of impurities in crude at the 0.1% level isolate and elucidate these impurity structures in just weeks not months! Reach out to our team at business@portonusa.com to connect with our scientists to discuss how Porton Pharma Solutions Ltd./J-STAR Research, Inc. can help you solve your Structural Elucidation challenges. Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #healthcare #Porton #drugproduct #drugsubstance #coprocessing #smallmolecules #API #processdevelopment #manufacture #customerfocus #structuralelucidation
关于我们
Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for small molecule, Large molecule and Gene and Cell Therapies from pre-clinical to commercialization. As of June 30, 2023, we have a proven record for the delivery of more than 2600 projects and established cooperation with more than 800 global clients. With our 5000+ skilled employees working across 20+ sites around the globe, Porton is committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world and enabling the public’s early access to good medicines. Porton is publicly listed on the Shenzhen Stock Exchange (Ticker: 300363). With over 5000 customer-centric employees, operations and commercial offices across the US, EU and China, Porton Pharma Solutions/J-Star Research provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and GMP manufacturing services across small molecule APIs, TIDES, biologics and Gene & Cell Therapies. We focus on the customer and have been recognized through awards by industry forums and global pharmaceutical companies for our process innovation, supply chain performance, and compliance with global Quality and EHS standards. We constantly strive for excellence and enable the public’s early access to good medicines.
- 网站
-
https://www.portonpharma.com/
Porton Pharma Solutions Ltd.的外部链接
- 所属行业
- 制药业
- 规模
- 5,001-10,000 人
- 总部
- Beibei,Chongqing
- 类型
- 上市公司
- 创立
- 2005
地点
Porton Pharma Solutions Ltd.员工
-
Keith Dodson
Executive Director Business Development and Head of US Marketing
-
Veronica Simionato, PMP®
Associate Director of PMO and Planning
-
Alexandra Pichard Nielsen
Vice President Business Development at Porton Pharma Solutions Ltd.
-
Pavlos Kouroupis
Senior VP Business Development @ Porton Pharma | Key Account Management
动态
-
Porton Pharma Solutions Ltd. & J-STAR Research, Inc. is proud to sponsor the GRC Conference, fostering innovation and excellence in the field of pharmaceutical sciences. Together, we are shaping the future of healthcare. Todd Nelson | Thorsten Rosner | Philip Wheeler Hope your day is packed with positivity! #follow us here https://lnkd.in/d64pQsdB
-
-
Porton Pharma Solutions Ltd.转发了
Prof. Olexandr Isayev of Carnegie Mellon University will be presenting “Crystal Structure Prediction for Realistic Pharmaceutical Targets with AIMNet2 Neural Network Potential”, at the 5th Pharma Crystallization Summit in Session 3 - Computational Applications for Controlled Crystallization. You can read the abstract at https://lnkd.in/eGuaRi3B. Please register now to secure your seat, at crystallizationsummit.com. We look forward to another exciting PCS with stimulating and fruitful sharing and discussions on the pressing topics in support of today’s new drug development. #PharmaCrystallizationSummit #DebottleneckingDrugDevelopment #ChallengingCrystallization #ParticleEngineering #ComputationTool
-
-
Porton Pharma Solutions Ltd.转发了
Prof. Susan M. Reutzel-Edens of SuRE Pharma Consulting will be presenting “Computer-aided solid form design: Current challenges, future opportunities”, at the 5th Pharma Crystallization Summit (#PCS2024) in Session 3 - Computational Applications for Controlled Crystallization. You can read the abstract at https://lnkd.in/eA6X4__8. Please register now to secure your seat, at crystallizationsummit.com We look forward to another exciting PCS with stimulating and fruitful sharing and discussions on the pressing topics in support of today’s new drug development. #PharmaCrystallizationSummit #DebottleneckingDrugDevelopment #ChallengingCrystallization #ParticleEngineering #ComputationTool
-
-
Technology-Driven | Porton's Crystallization Team And Genentech Jointly Published Breakthrough Results In 《Pharmaceutical Research》 Recently, the #crystallization team at Porton Pharma Solutions Ltd. and Genentech, Inc. jointly published a paper titled "Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound" in 《Pharmaceutical Research》, the official journal of the American Association of Pharmaceutical Scientists. This journal focuses on publishing new research results in the combined areas of #medicine and #chemistry. Read more here: https://lnkd.in/eadP4a53 Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB Shanming Kuang | Harsh S. Shah, Ph.D. | Baoshu Z. #pharmaceuticalscience #dehydration #API #researchInnovation #pharmceuticalresearch #healthcare
-
-
J-Star Open House and Summer BBQ On June 28, 2024, Porton J-STAR Research, Inc. officially inaugurated two Cranbury, New Jersey facilities for integrated Drug Substance (DS) and Drug Product (DP) services, GMP clinical hashtag #manufacturing operations, and our new HPAPI laboratories during the Open House and #Summer BBQ event. These newest facilities are equipped with advanced capabilities in Drug Product development, #GMP clinical delivery, #formulation R&D, solid-state studies, #crystallization process development, particle engineering, DS-DP #coprocessing, and the expanding #HPAPI capabilities including encompassing R&D, GMP production, and DS synthesis through crystallization and #formulation. We extend our heartfelt gratitude to everyone who attended and contributed to the success of this remarkable event. Your presence and active engagement truly made a difference, and the Porton J-Star team looks forward to supporting your programs in the months and years to come. #Reach out to us at Business@PortonUSA.com to schedule your visit and to connect with our team of experts. Schedule a #meeting here: https://lnkd.in/eFzuWJBN Wenfang Miao | Todd Nelson| Yihui Chen | Keith Drouet | Keith Dodson | Eric Hohenschuh | Thorsten Rosner | Sunny LIU | Hui Chen | Hugh Huang | San Kiang| Philip Wheeler | Yuriy Abramov | Jian Wang Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #Porton #drugproduct #drugsubstance #API #processdevelopment #teamwork #customerfocus #healthcare
-
-
Porton Pharma Solutions Ltd. and J-STAR Research, Inc. is a leading provider in the pharmaceutical industry, known for its commitment to innovation and excellence in drug product research and development (R&D). With a dedicated team of experts and state-of-the-art facilities, we leverage cutting-edge technologies and a robust scientific foundation to devise novel therapeutics that address unmet medical needs. Porton J-Star excels in translating complex scientific discoveries into viable drug products, expediting the journey from molecule to market. As your dosage form experts, we are committed to achieving optimal drug delivery, bioavailability, and formulation stability. Please feel free to reach out to us at Business@portonusa.com to learn more. Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #Porton #drugproduct #drugsubstance #coprocessing #smallmolecules #API #processdevelopment #manufacture #teamwork #customerfocus
-
-
🌟 Exciting Announcement 🌟
Dr. Rajni M. Bhardwaj of Pfizer will be presenting “Solid Form Design and Selection Utilizing Combined Experimental and Computational Techniques”, at the 5th Pharma Crystallization Summit in Session 3 - Computational Applications for Controlled Crystallization. You can read the abstract at https://lnkd.in/eKnGEBrM. Please register now to secure your seat, at crystallizationsummit.com We look forward to another exciting PCS with stimulating and fruitful sharing and discussions on the pressing topics in support of today’s new drug development. #PharmaCrystallizationSummit #DebottleneckingDrugDevelopment #ChallengingCrystallization #ParticleEngineering #ComputationTool
-
-
🌟 Exciting Announcement 🌟 June 2024 — Porton Pharma Solutions Ltd. & J-STAR Research, Inc. today announced that Enabling Technologies Consortium ETC®has awarded a two-year contract to J-STAR to collaborate on “Co-processing Platform Technology.” Dr. San Kiang The primary goal of co-processing is to improve the reliability and efficiency of drug product manufacturing processes to support direct compression or continuous manufacturing techniques. Co-processed APIs offer solutions to challenges like inadequate powder flow, low bulk density, broad particle size distribution, and compressibility, facilitating direct compression. When traditional methods such as API crystallization through solvent selection, supersaturation control, seeding, or milling techniques are insufficient, co-processing of API with excipients can significantly improve the functional properties to overcome these challenges. Read more here: https://lnkd.in/e8Xr7fyA Reach out to our team at https://lnkd.in/ePQvcH_B Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB
-
-
🌟 Exciting Announcement 🌟 On June 14, 2024, Dr. Francesco Fontana (R&D Director), Dr. Dario Telese, Ph.D. Telese (Lead Chemist), and Dr. Lucija Ptiček (Synthesis Laboratory Specialist) from the Porton Slovenian site presented a lecture on the Master PRO-API program of the University of Perugia. The lecture, titled "Introduction to the Green Chemistry Metrics – Innovation Green Aspiration Level (iGAL)," The post-graduate master training program designed to prepare young graduates and post-graduates for careers as Process Chemists in the pharmaceutical industry. Read more here: https://lnkd.in/emEnJUUb Reach out to our team at https://lnkd.in/ePQvcH_B Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB
-